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pROtOCOL ARtICLE
Work-related adjustment disorder (WAD) or “stress” is 
one of the costliest disorders of modern society and a 
major cause of lost earnings in the Danish corporate 
sector [1]. A rising WAD prevalence is the companion 
of a high occupational frequency [2]. Reports demon-
strate a clear correlation between psychosocial stress-
ors in the work environment and mental disorders, in-
cluding dementia [3] and cardiovascular disease [4, 5]. 
Scientifically validated analyses point to job insecurity, 
lack of influence on own work situation and failing sup-
port from management and colleagues as the prevail-
ing causes of this condition [6]. The pathology of stress 
is largely unknown in terms of the underlying neurobi-
ology, other than that of stress hormones, and there is a 
shortage of studies exploring any links among psycho-
social work stressors, brain metabolism and signal 
transmission. 
The major reward substance dopamine (DA) ap-
pears to be crucial to reward and motivation, but DA 
neurotransmission in the prefrontal cortex has been 
shown also to play an essential role in mediating execu-
tive functions [7, 8]. Executive functions are the basis 
of competencies favoured by modern society, including 
motivation and learning – and executive abilities such 
as planning, focus, concentration and problem solving. 
The dopaminergic structures underlying these func-
tions are the mesolimbic and mesocortical DA path-
ways (Figure 1), referred to jointly as the mesocortico-
limbic projection. The mesolimbic DA pathway is the 
primary neural network of reward, and it connects the 
ventral tegmental area (VTA), a principal DA-produc-
ing site in the brain, to the nucleus accumbens, a site 
below the ventral striatum that is strongly associated 
with motivation and reward anticipation [9]. The mes-
ocortical DA pathway passes from the VTA to the cere-
bral cortex as part of the reward circuitry that is active 
during cognition and executive decision-making [7]. 
We hypothesise that functional changes in the brain’s 
DA-based mesocorticolimbic projections in patients di-
agnosed with WAD are manifested as altered regional 
glucose metabolism in the target areas of the meso-
corticolimbic projections, as an expression of altered 
neural activity and DA radiotracer binding potential at 
the sites of interaction between neurotransmitter and 
receptors.  
METHODS
Occupational health
Recruitment procedure
The Department of Occupational and Environmental 
Medicine in Odense will recruit patients with WAD 
meeting the criteria of the International Classification 
of Diseases, tenth version (ICD10) F43.2x through ex-
posure to predominantly psychosocial work stressors.
Recruitment criteria
Patients are women aged 34-54 years with a bachelor 
level education who represent the largest affected 
group in the Danish workforce [10]. They undergo a 
clinical diagnostic interview based on the ICD10 crit-
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our society and often implies impairments in cognitive and 
emotional functions. Here, we hypothesise that changes in 
the brain’s dopamine (DA)-based mesocorticolimbic projec-
tions in patients with work-related stress (adjustment 
disorder) will manifest themselves as altered glucose 
metabolism in relation to neural activity, and as altered DA 
radiotracer binding potentials at the relevant receptors.
METHODS: Subjects and healthy controls undergo 
neuropsychiatric tests and PET/MRI with three tracers;  
18F- fluorodeoxyglucose to measure glucose metabolism as 
a marker of neural activity, 11C-raclopride to explore binding 
potentials in the striatum, and 11C-FLB 457 to study possibly 
impaired mesocortical dopaminergic transmission in the 
cortex. To demonstrate differences of glucose metabolism, 
more than 2 × 41 patients/controls are needed. We expect to 
find that symptoms of cognitive and motivational reward 
deficits are attributable to changes in the frontal lobe and 
striatal glucose metabolism in the majority of patients, and 
that changes of D2-receptor availability and impaired 
dopaminergic transmission in the striatum and prefrontal 
cortex are contributing factors.
CONCLUSIONS: This project is designed to generate entirely 
new and objective evidence of stress-induced cerebral 
illness, and to provide a basis for in-depth research and for 
a more rational management of this strenuous disorder.
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eria, including screening for stressors in the psycho-
social work environment and the relationships of the 
stressors to disease development, private-life strains, 
personal background, mental vulnerability and com-
peting somatic disease, as well as tests for depression 
and anxiety symptoms, respectively, as measured by 
the Beck Anxiety Inventory and the Major Depression 
Inventory. The screening for psychosocial work envir-
onment stressors includes: quantitative demands, emo-
tional demands, role conflict, role ambiguity, support 
and encouragement, organisational justice, adequate 
education and training (skill level). The experience of 
stressors is assessed in relation to the most dominant 
stress models, “demand-control-support” (Karasek), 
“effort and reward imbalance at work” (Siegrist), 
“Stress as Offense to self” (Semmer) and classic stress 
theory focusing on appraisal and coping (Lazarus or 
Ursin). In connection with the scans, a Schedules for 
Clinical Assessment in Neuropsychiatry-Present State 
Examination interview for the assessment of mental 
symptoms will be conducted to determine if the partici-
pant’s condition has changed since the first diagnosis. 
Healthy controls are recruited and matched with re-
gard to gender, age, and educational and occupational 
background. See Table 1, Table 2 and Table 3 for in-
clusion-, exclusion- and withdrawal criteria.
Positron emission tomography
Radiotracer 18F-FDG study
18F-fluorodeoxyglucose (FDG) PET is the primary imag-
ing tracer, which measures glucose metabolism in the 
brain as an indicator of neural activity [11]. We will  
examine whether symptoms of cognitive and motiva-
tional or reward deficits are attributable to frontal-lobe 
and striatal changes in glucose metabolism in F43.2x 
patients compared to a control group. Initially, we will 
investigate global glucose consumption in patients ver-
sus control subjects. In addition, we will investigate  
regional differences in glucose metabolism in the stria-
tum connected to the reward circuitry of the meso-
limbic DA projection. We will then focus on the pre-
frontal, dorsolateral prefrontal and anterior cingulate 
cortex as these regions of interest are known to be 
strongly involved in the executive circuits of working 
memory and attention, including the DA’s influence on 
the performance of working-memory tasks [12-14]. 
The following two sub-projects will test that alterations 
can be linked to altered neural activity and to DA radio-
tracer binding potential at sites where the neurotrans-
mitter and receptor interact.
Radiotracer 11C-raclopride study
This study addresses the possible changes of the brain’s 
reward system’s dependence on DA, performed as a 
PET imaging of the binding of the radiotracer 11C-raclo-
pride, commonly used to determine the binding poten-
tial at D2/3 receptors in the striatum. Raclopride acts 
as a selective antagonist at D2/3 DA receptors. During 
scans, the participants will perform neuropsychological 
reward and executive tasks, to activate the regions of 
reward and executive functions of the brain, respect-
ively. The tests include the Monetary Reward Task, and 
for executive functions the Stroop Test. Apart from in-
vestigation of baseline conditions, these tests also allow 
us to study function-related neurobiological activity 
during performance. In addition, they provide data to 
evaluate if patients on average actually show deficits of 
performance compared to control subjects.
Radiotracer 11C-FLB 457 study
Cognitive deficits and reduced abilities to perform ex-
ecutive functions are believed to be related to possibly 
impaired mesocortical dopaminergic transmission in 
the extrastriatial regions of the prefrontal cortex [12]. 
11C-FLB 457 is a radiotracer with greater affinity for D2 
receptors than raclopride, and it is therefore more suit-
able for imaging of DA receptors in the cortical DA pro-
jection [15]. The main regions of interest in this inves-
tigation are the dorsolateral prefrontal cortex, the 
orbitofrontal cortex, the medial prefrontal cortex and 
the anterior cingulate cortex. The methods used are 
similar to those of the raclopride study, including task 
performance. 
Considerations relating to the statistical analysis
Descriptive statistics will be performed according to 
data type (categorical variables: frequencies and re-
FIGURE 1
Dopamine pathways. 
Reproduced with per-
mission from Dr. Oscar 
Arias-Carrion.
SNc = substantia nigra 
pars compacta; VTA =  
ventral tegmental area.
Blue frontal: mesocortical 
projection; green: meso-
limbic projection.
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spective percentages; continuous variables: mean and 
standard deviation or median and range, depending on 
the skewness of data as assessed by means of histo-
grams and approximating normal distributions). Paired 
differences of quantitative measures (such as glucose 
consumption and binding potentials at a given time 
point) between patients and age- and gender-matched 
control subjects will be analysed with the paired t-tests 
and Wilcoxon’s rank sign test, pending distributional 
assumptions of the differences and sample size. 
Changes from baseline to task-induced activity will be 
related to baseline, resulting in percentage changes 
over time; the group difference will then be assessed as 
the difference between these respective changes over 
time in patients and control subjects, respectively. The 
significance level for exploratory testing will be a prob-
ability of random effects of less than 5%. Stata 14.2/SE 
(StataCorp LP, College Station, Texas 77845 USA) will 
be used for all analyses. 
Sample size
PET measures of whole-brain glucose metabolism with 
FDG generally average 25 ± 8 (standard deviation) 
µmol/hg/min. To detect a difference of at least 20% in 
either direction [16] with a power of 80% and a signifi-
cance level of 5%, at least 41 subjects must be tested in 
each of the two groups or the two conditions that are 
compared, totaling n = 82 in the study. Due to the nov-
elty of the investigation, an interim analysis will be per-
formed with 20 patients and 20 controls, which will 
trigger early stop due to futility if the difference is 5% 
or less in either direction. Otherwise, the study will be 
continued until the total sample size of 82 is reached. 
Ethical considerations
Applying PET technology to research always requires 
considerations about radiation parameters. In this pro-
ject, due to new and highly sensitive PET detectors, a 
PET session with FDG results in an estimated additional 
radiation dose of about 3 mSv, which is comparable to 
the natural background radiation per year in Denmark 
of 4 mSv. The radiation from 11C-raclopride or 11C-FLB 
457 is approximately half that dose [17, 18] with rapid 
decay (T½ = 20 min.), indicating a total radiation dose 
of 6 mSv when all three sessions are completed in the 
same subject. According to the guidelines of the Danish 
National Committee on Health Research Ethics, this 
qualifies the project for category IIb designation, con-
sistent with an increase of the theoretical risk of dying 
of cancer later in life from 25.00% to 25.03% [19]. It is 
noteworthy that at present the American Association  
of Physicists in Medicine states that there is no convinc-
ing epidemiological evidence of increased cancer inci-
dence or mortality from radiation doses lower than 100 
mSv. 
Outcome 
We expect to find significant changes of global and re-
gional estimates of cerebral glucose metabolism in 
more than half of the patients compared to control sub-
jects. In addition, we expect to find changes of raclo-
pride binding to D2/3 receptors in the striatum and 
FLB 457 binding to D2/3 receptors in cortical DA pro-
jections. 
Trial registration: Clinicaltrails.gov/NCT033340- 
45.
TABLE 1
Inclusion criteria: participants.
Population and controls
Informed consent before study-related activity
Age 18-64 years
Labour market suitability
Study population
Patients: F43.2
Controls: healthy individuals who meet the inclusion and exclusion  
criteria
TABLE 2
Exclusion criteria: population, patients and controls.
Comorbid diagnoses, e.g.: cancer, cardiovascular disease and diabetes
Regular medication known to affect the central nervous system
Prior exposure to violence and other serious harassment at the  
workplace
Psychosocial challenge in private life according to the screening criteria 
in the protocol
Other serious illness 
Metal in body, pacemakers included
Claustrophobia
Pregnancy
Confounding drug consumption
Dependence, e.g., alcohol, narcotics or other
Persons who within one year before entrance participated in scientific 
studies that used isotopes, or who underwent greater diagnostic tests 
that utilise ionizing radiation
TABLE 3
Withdrawal criteria.
Withdrawal of informed consent
Serious development of participant’s medical condition or other illness
Unfitness of the participant which – in the investigator’s opinion –  
requires that the participant is withdrawn from the study
Change in medication between positron emission tomographies
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DISCUSSION
Despite mounting evidence of detrimental effects of oc-
cupational stress on the cognitive and emotional func-
tions of the brain, the underlying mechanisms remain 
largely unknown. In preliminary inquiries, we found 
that patients often report that their surroundings ques-
tion the notion that stress-related disabilities represent 
a medical condition. Indeed, the ICD10 code F43.2x 
covers a wide spectrum of symptoms with links to de-
pression, stress and anxiety spectrums, including de-
pressed mood, anxiety, worry, feeling of powerless-
ness, confusion, and cognitive symptoms of fatigue, 
memory problems and difficulties concentrating. How-
ever, with the prevalence of stress at a daily average 
cost of 112 million DKK in lost earnings and healthcare 
expenses, stress is a condition with effects that go far 
beyond the individual patient. 
From a neurobiological perspective, the diagnostic 
criteria address several functions, and a successful 
study outcome demands rigorous procedures and re-
quires an interdisciplinary approach to the science. The 
project focuses on the neuropathology of emotional 
and cognitive aspects of the F43.2x diagnosis in pa-
tients exposed to psychosocial stressors in their work 
environment, as these aspects appear to be by far the 
least studied elements of the F43.2x diagnosis. This is 
so despite a sense that these aspects in particular seem 
to be the ones most readily examined, considering that 
major causes of work-related stress are of this kind. 
Structural studies also clearly suggest that stress can be 
associated with changes in brain structures and reduc-
tions of gray matter volume in the regions of interest 
[20]. This project may generate entirely new know-
ledge of brain functions. Thus, the mere finding of ob-
jective evidence of stress-induced cerebral illness will 
be a major achievement in itself.
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